There's more to Merck's Ebola vaccine than money By: CNBC.com News July 31, 2015 at 14:18 PM EDT A vaccine being developed by Merck and NewLink was shown to be 100 percent effective, but does this mean they'll make big bucks? Read More >> Related Stocks: Gsk Plc ADR Johnson & Johnson Merck & Co Newlink Genetics Cor